Answer
Jun 23, 2026 - 11:08 AM
Yes — Trimbow is generally considered a “strong” COPD inhaler because it is a triple-therapy maintenance inhaler. It combines three medicines in one inhaler:
The patient leaflet says Trimbow is used for the regular treatment of COPD in adults, helps relieve/prevent breathlessness, wheeze, and cough, and can reduce COPD flare-ups/exacerbations.
In practical terms, doctors usually consider it a step-up inhaler for people whose COPD is not well controlled on simpler inhalers, such as one or two maintenance medicines. EMA describes Trimbow as a treatment for moderate to severe COPD.
But “strong” does not mean it works like a rescue inhaler. Trimbow is for daily maintenance, not sudden attacks. The leaflet says not to use it to relieve a sudden attack of breathlessness or wheezing; you should use your quick-acting reliever inhaler for that.
The main tradeoff is that because it includes an inhaled steroid, it may be more suitable for people with COPD flare-ups or certain inflammation patterns, but it can also increase steroid-related risks such as oral thrush and, in some COPD patients, pneumonia risk. Your doctor weighs that against the benefit of fewer flare-ups.
| Component | Type | What it does |
|---|---|---|
| Beclometasone | Inhaled corticosteroid (ICS) | Reduces airway swelling and irritation |
| Formoterol | Long-acting bronchodilator (LABA) | Helps relax and open the airways |
| Glycopyrronium | Long-acting bronchodilator (LAMA) | Helps keep the airways open |
In practical terms, doctors usually consider it a step-up inhaler for people whose COPD is not well controlled on simpler inhalers, such as one or two maintenance medicines. EMA describes Trimbow as a treatment for moderate to severe COPD.
But “strong” does not mean it works like a rescue inhaler. Trimbow is for daily maintenance, not sudden attacks. The leaflet says not to use it to relieve a sudden attack of breathlessness or wheezing; you should use your quick-acting reliever inhaler for that.
The main tradeoff is that because it includes an inhaled steroid, it may be more suitable for people with COPD flare-ups or certain inflammation patterns, but it can also increase steroid-related risks such as oral thrush and, in some COPD patients, pneumonia risk. Your doctor weighs that against the benefit of fewer flare-ups.
